Dr. Anuya Nisal meets Dr. Kiran Mazumdar Shaw at CSIR-NCL's Platinum Jubilee Celebrations Dr. Anuya Nisal had the honour to meet Dr. Kiran Mazumdar Shaw – a true pioneer who…
Seriderm - Our Advanced Wound Dressing for Expedited Healing is Now Available on GeM Portal We are happy to share that Seriderm, our cutting-edge silk-based wound dressing is being used…
Serigen closes a Pre-Series A Funding Round of Rs 10 Cr ($1.2M) We're thrilled to announce that Serigen has raised a Pre-Series A funding of Rs 10 Crore ($1.2M)! We…
Serigen recognised as Health-Tech Startup of the Year at the HTG Pune Summit 2024! Serigen was recognised as the Health-Tech Startup of the Year at the HTG Pune Summit-2024 organised…
Serigen wins a Special Recognition Award at the 8th International Diabetes Summit by Chellaram Diabetes Institute Rucha Deshpande Ph.D from Serigen has won a Special Recognition Award at the 8th…
Serigen wins the 9th National Award for Polymers in Public Healthcare by the Department of Chemicals and Petrochemicals, GoI Serigen has been awarded the 9th National Award for Polymers in…
Serigen wins the Poster Pitch Competition at the ORS 2024 Annual Meeting of the Orthopaedic Research Society, USA Serigen emerged as a winner in the Poster Pitch Competition at the…
Serigen wins the prestigious Biotechnology Ignition Grant from DBT-BIRAC Serigen (previously BiolMed) has been selected for the prestigious Biotechnology Ignition Grant for its flagship product Serioss. Biotechnology Ignition grant is…
BIRAC awards SBIRI grant to Serigen Serigen (previously BiolMed)is the proud recipient of the Small Business Innovation Research Initiative (SBIRI) grant by Biotechnology Industry Research Assistance Council (BIRAC). BIRAC is…
Serigen receives the DBT-BIRAC-BIPP grant funding Serigen (previously BiolMed) has been selected for the Biotechnology Industry Partnership Program (BIPP) funding scheme. BIPP is implemented by Biotechnology Industry Research Assistance Council…
Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.
Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.
Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.
Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.
Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.
